Sun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
14/06/2024 15:33

Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial Demonstrates Durability of Pain Relief After a SIngle Injection of MM-II in Patients with Painful Knee Osteoarthritis (OA)